CinCor Pharma, Inc.
CinCor Pharma, Inc. (CINC) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · CINC · as of Jun 8, 2026
Key Statistics
Explore CinCor Pharma, Inc. Data
cinc stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 7 · Buy rate: 57.1%
The CINC analyst consensus is Buy, based on ratings from 7 Wall Street analysts over the past 3 months. The average 12-month price target is $48.50, representing +66.90% upside from the current price of $29.06.
Competitors & Peers
cinc competitorsCINC
ALBO
CTIC
EQRX
ETHZ
GRCLStock Performance
Full HistoryAbout CinCor Pharma, Inc.
CinCor Pharma, Inc. is an emerging biopharmaceutical firm in the clinical development phase, dedicated to pioneering therapeutic solutions for cardiovascular and renal conditions. At the core of its p…
what is cincor pharma, inc. · cinc stock overview · cincor pharma, inc. company profile · who is cincor pharma, inc. ceo · cinc NASDAQ · cincor pharma, inc. headquarters · cincor pharma, inc. business segments
About Stock Overview & Key Data
CinCor Pharma, Inc. (CINC) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Jan 7, 2022. As of the latest trading session, CINC stock price is $29.06, with a market capitalization of $1.3B. The stock has returned +62.35% over the past 12 months and +147.32% year-to-date.
According to 7 Wall Street analysts, the consensus rating for CinCor Pharma, Inc. stock is Buy, with an average 12-month price target of $48.50. In fiscal year 2021, CinCor Pharma, Inc. reported revenue of — and net income of -$50.3M. For detailed data — including CinCor Pharma, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, CinCor Pharma, Inc. (CINC) stock price is $29.06. The stock is traded on NASDAQ under the ticker symbol CINC. The 52-week range is $10.53 – $43.15.